Nagihan Kolkıran

4PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 26, 2026
Composite CA15-3, LDH, and Albumin Index as a Predictor of Survival in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine.

|Mar 28, 2026
Modified Aarhus Composite Biomarker Score as a New Risk-Stratification Tool in Metastatic Colorectal Cancer.

Nagihan Kolkıran, Atike Pınar Erdoğan, Mustafa Şahbazlar

|Oct 28, 2025
SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab.

Nagihan Kolkıran, Atike Pınar Erdoğan, Mustafa Şahbazlar

|Jan 11, 2025
Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study.

Salih Tünbekici, Haydar Cagatay Yuksel, Caner Acar

Pageof 1

Frequent Collaborators

2 joint publications

Mustafa Şahbazlar

1 joint publications

Salih Tünbekici

1 joint publications

Haydar Cagatay Yuksel

1 joint publications

Caner Acar